Genzyme reports five-year alemtuzumab Phase 2 data
Alemtuzumab is a humanized monoclonal antibody used as a potential therapy to treat relapsing-remitting multiple sclerosis. In the trial, alemtuzumab was given to patients in two or three
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
The fingerprint technology discerns the so-called forensic ‘fingerprint’ of herbal medicine components using advanced techniques including chromatographic or spectral profiling. The profile can be used to identify different
Modufolin (6R-5,10-methylenetetrahydrofolate) is a novel folate-based drug developed to increase the efficacy and reduce the side effects of antimetabolites used in cancer treatment. However, Eli Lilly’s Alimta is
Sativex is an endocannabinoid modulator made of two actives – THC (delta-9-tetrahydrocannabinol) and CBD (cannabidiol). It was developed and is manufactured by GW Pharmaceuticals. GW Pharmaceuticals’ marketing partner